BIOALLIANCE PHARMA FILES FOR EUR30M IPO ON EURONEXT IN PARIS

BioAlliance Pharma SA launched an IPO on Eurolist Compartment C of the Euronext stock exchange in Paris with the aim of raising ⁈29.5 to ⁈33.8 million and, in the words of its chairman and co-founder, Dominique Costantini, of "transmuting from a drug discovery company into a profitable pharmaceutical company."
BioWorld Today